Register entry
ELYSIUM PHARMACEUTICALS LIMITED
- Registered sites
- 1
- Drug products
- 27
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Elysium Pharmaceuticals Ltd | VadodaraIndia | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3005183272 |
Catalogue
Marketed products
27Showing 27 of 27.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen ,Dextromethorphan Hydrobromide, Doxylamine succinate | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen 325mg, Guaifenesin 200mg, Dextromethorphan HBr 10mg, Phenylephrine HCl 5 mg | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Diphenhydramine Hydrochloride | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Diphenhydramine Hydrochloride | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Aspirin | TABLET, DELAYED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | Dextromethorphan Hydrobromide Capsules | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride 25 | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Folic Acid | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin and dextromethorphan HBR | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Phenylephrine Hydrochloride | TABLET | DRUG FOR FURTHER PROCESSING |
| Purpose Dual Treatment SPF 10 | Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3% | LOTION | OTC MONOGRAPH DRUG |
| - | Sennosides Tablets 8.6 | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Simethicone | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | Simethicone 180 | CAPSULE, LIQUID FILLED | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen aspirin and caffeine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen pyrilamine maleate and caffeine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | acetaminophenand caffeine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | sodium chloride | TABLET, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.